US2006223990A1PendingUtilityA1
Synthesis, deprotection, analysis & purification of RNA & ribozymes
Est. expiryMay 11, 2012(expired)· nominal 20-yr term from priority
Inventors:Nassim UsmanFrancine WincottDavid SweedlerLeonid BeigelmanLech DudyczSusan GrimmAnthony DirenzoDanuta Tracz
A61P 31/22A61P 35/02A61P 31/18A61P 31/12A61P 31/14A61P 31/16C12N 15/86A61P 1/16C12N 2310/3521C12Q 1/706A61K 38/00C12N 2310/123C12N 2310/321C07H 19/06C12N 15/113C12N 15/1003C12N 2710/16622C12N 2740/14043C12N 2730/10122C12N 15/85C12N 2310/121C12N 2310/3535C12N 2310/53C12N 2310/12C12N 2770/24222C12N 2310/122C12N 2310/111C12N 2310/3533C12N 2310/315C12N 2310/322C12Q 1/701C12N 2310/3531C12N 15/1131C07K 14/005
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
Claims
exact text as granted — not AI-modified1 . A process for chemically synthesizing, deprotecting, and purifying RNA having one or more chemical modifications, comprising:
a. contacting a phosphoramidite with S-alkyltetrazole under conditions for synthesizing said RNA; b. contacting said RNA with an alkylamine under conditions for removing any exocyclic amine protecting groups or phosphate ester protecting groups; c. contacting said RNA with triethylamine-hydrogen fluoride under conditions to remove any alkylsilyl protecting groups from said RNA; d. loading said RNA onto an anion exchange high-performance liquid chromatography (HPLC) column; e. eluting said RNA by passing a buffer through said column; and f. collecting the eluate from said column and recovering said RNA from said eluate, under conditions which allow for the purification of said RNA.
2 . The process of claim 1 , wherein said RNA is provided as a sodium, potassium, or magnesium salt.
3 . The process of claim 1 , wherein said RNA is provided in desalted form.
4 . The process of claim 1 , wherein said anion exchange column comprises resins that are either quaternary or tertiary amino derivatized stationary phases.
5 . The process of claim 4 , wherein said resin is either silica-based or polystyrene based.
6 . The process of claim 1 , wherein said RNA comprises a plurality of chemical modifications.
7 . The process of claim 1 , wherein said chemical modification is a sugar modification.
8 . The process of claim 1 , wherein said chemical modification is a base modification.
9 . The process of claim 1 , wherein said chemical modification is a phosphate backbone modification.
10 . The process of claim 7 , wherein said sugar modification is a 2′-O-methyl modification.
11 . The process of claim 7 , wherein said sugar modification is a 2′-deoxy-2′-amino modification.
12 . The process of claim 7 , wherein said sugar modification is a 2′-deoxy-2′-fluoro modification.
13 . The process of claim 9 , wherein said phosphate backbone modification is a phosphorothioate modification.
14 . The process of claim 1 , wherein said RNA is chemically synthesized using solid phase synthesis.
15 . The process of claim 1 , wherein said S-alkyltetrazole is S-ethyltetrazole.
16 . The process of claim 1 , wherein said alkylamine is methylamine.
17 . The process of claim 1 , wherein said alkylamine is ethylamine.
18 . The process of claim 1 , wherein said alkylamine is triethylamine.Join the waitlist — get patent alerts
Track US2006223990A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.